南新制药：8月公司未实施股份回购

Core Viewpoint - Nanjing New Pharmaceutical (688189.SH) announced that as of August 31, 2025, it has not implemented any share buybacks, having repurchased a total of 265,516 shares, which represents 0.10% of the company's total share capital of 274,400,000 shares [1] Summary by Relevant Categories Share Buyback Activity - The company repurchased 265,516 shares through the Shanghai Stock Exchange's centralized bidding system [1] - The highest price for the repurchased shares was 7.86 CNY per share, while the lowest price was 7.02 CNY per share [1] - The total amount paid for the repurchased shares was 1,967,393.92 CNY, excluding stamp duty and transaction commissions [1]